BCR and B-cell chronic lymphocytic leukemia: Here we report comprehensive characterization of CLL and healthy B cells expressing the R110-mutated IGLV3-21 LC (termed IGLV3-21R110) by extensive BCR sequencing, development of IGLV3-21– and IGLV3-21R110–specific antibodies, and mass cytometry analyses.